ATR kinase activation in G1 phase facilitates the repair of ionizing radiation-induced DNA damage

Nucleic Acids Research

Volumn 41, Issue 22, 2013, Pages 10334-10344

  Gamper, Armin M ^a   Rofougaran, Reza ^a   Watkins, Simon C ^a   Greenberger, Joel S ^a   Beumer, Jan H ^b   Bakkenist, Christopher J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATR PROTEIN; CHECKPOINT KINASE 1; REPLICATION FACTOR A;

ARTICLE; CELL CYCLE G1 PHASE; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; PRIORITY JOURNAL;

ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL LINE; DNA DAMAGE; DNA REPAIR; G1 PHASE; HUMANS; PROTEIN KINASES; RADIATION TOLERANCE; RADIATION, IONIZING; REPLICATION PROTEIN A; SIGNAL TRANSDUCTION;

EID: 84890420876     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt833     Document Type: Article

References (41)

1. Ciccia, A. and Elledge, S.J. (2010) The DNA damage response: making it safe to play with knives. Mol. Cell, 40, 179-204.
2. Sorensen, C.S. and Syljuasen, R.G. (2012) Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication. Nucleic Acids Res., 40, 477-486.
3. Cliby, W.A., Roberts, C.J., Cimprich, K.A., Stringer, C.M., Lamb, J.R., Schreiber, S.L. and Friend, S.H. (1998) Overexpression of a kinase-inactive ATR protein causes sensitivity to DNAdamaging agents and defects in cell cycle checkpoints. EMBO J., 17, 159-169.
4. Wright, J.A., Keegan, K.S., Herendeen, D.R., Bentley, N.J., Carr, A.M., Hoekstra, M.F. and Concannon, P. (1998) Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control. Proc. Natl Acad. Sci. USA, 95, 7445-7450.
5. Jazayeri, A., Falck, J., Lukas, C., Bartek, J., Smith, G.C., Lukas, J. and Jackson, S.P. (2006) ATM-and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat. Cell Biol., 8, 37-45.
6. Huertas, P. and Jackson, S.P. (2009) Human CtIP mediates cell cycle control of DNA end resection and double strand break repair. J. Biol. Chem., 284, 9558-9565.
7. You, Z. and Bailis, J.M. (2010) DNA damage and decisions: CtIP coordinates DNA repair and cell cycle checkpoints. Trends Cell Biol., 20, 402-409.
8. Kousholt, A.N., Fugger, K., Hoffmann, S., Larsen, B.D., Menzel, T., Sartori, A.A. and Sorensen, C.S. (2012) CtIP-dependent DNA resection is required for DNA damage checkpoint maintenance but not initiation. J. Cell Biol., 197, 869-876.
9. Painter, R.B. and Young, B.R. (1980) Radiosensitivity in ataxiatelangiectasia: a new explanation. Proc. Natl Acad. Sci. USA, 77, 7315-7317.
10. Brown, E.J. and Baltimore, D. (2000) ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev., 14, 397-402.
11. de Klein, A., Muijtjens, M., van Os, R., Verhoeven, Y., Smit, B., Carr, A.M., Lehmann, A.R. and Hoeijmakers, J.H. (2000) Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice. Curr. Biol., 10, 479-482.
12. Liu, Q., Guntuku, S., Cui, X.S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A. et al. (2000) Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev., 14, 1448-1459.
13. Takai, H., Tominaga, K., Motoyama, N., Minamishima, Y.A., Nagahama, H., Tsukiyama, T., Ikeda, K., Nakayama, K., Nakanishi, M. and Nakayama, K. (2000) Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. Genes Dev., 14, 1439-1447.
14. Srinivasan, A., Wang, L., Cline, C.J., Xie, Z., Sobol, R.W., Xie, X.Q. and Gold, B. (2012) Identification and characterization of human apurinic/apyrimidinic endonuclease-1 inhibitors. Biochemistry, 51, 6246-6259.
15. Siegfried, J.M., Krishnamachary, N., Gaither Davis, A., Gubish, C., Hunt, J.D. and Shriver, S.P. (1999) Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer. Pulm. Pharmacol. Ther., 12, 291-302.
16. Toledo, L.I., Murga, M., Zur, R., Soria, R., Rodriguez, A., Martinez, S., Oyarzabal, J., Pastor, J., Bischoff, J.R. and Fernandez-Capetillo, O. (2011) A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations. Nat. Struct. Mol. Biol., 18, 721-727.
17. Charrier, J.D., Durrant, S.J., Golec, J.M., Kay, D.P., Knegtel, R.M., MacCormick, S., Mortimore, M., O'Donnell, M.E., Pinder, J.L., Reaper, P.M. et al. (2011) Discovery of potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase as potential anticancer agents. J. Med. Chem., 54, 2320-2330.
18. Hickson, I., Zhao, Y., Richardson, C.J., Green, S.J., Martin, N.M., Orr, A.I., Reaper, P.M., Jackson, S.P., Curtin, N.J. and Smith, G.C. (2004) Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res., 64, 9152-9159.
19. Smith, J., Tho, L.M., Xu, N. and Gillespie, D.A. (2010) The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv. Cancer Res., 108, 73-112.
20. Bunting, S.F., Callen, E., Wong, N., Chen, H.T., Polato, F., Gunn, A., Bothmer, A., Feldhahn, N., Fernandez-Capetillo, O., Cao, L. et al. (2010) 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell, 141, 243-254.
21. Graves, P.R., Yu, L., Schwarz, J.K., Gales, J., Sausville, E.A., O'Connor, P.M. and Piwnica-Worms, H. (2000) The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J. Biol. Chem., 275, 5600-5605.
22. Johnson, S.M., Torrice, C.D., Bell, J.F., Monahan, K.B., Jiang, Q., Wang, Y., Ramsey, M.R., Jin, J., Wong, K.K., Su, L. et al. (2010) Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition. J. Clin. Invest., 120, 2528-2536.
23. Barr, S.M., Leung, C.G., Chang, E.E. and Cimprich, K.A. (2003) ATR kinase activity regulates the intranuclear translocation of ATR and RPA following ionizing radiation. Curr. Biol., 13, 1047-1051.
24. Lukas, J., Pagano, M., Staskova, Z., Draetta, G. and Bartek, J. (1994) Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene, 9, 707-718.
25. Wohlschlegel, J.A., Dwyer, B.T., Dhar, S.K., Cvetic, C., Walter, J.C. and Dutta, A. (2000) Inhibition of eukaryotic DNA replication by geminin binding to Cdt1. Science, 290, 2309-2312.
26. Nishitani, H., Sugimoto, N., Roukos, V., Nakanishi, Y., Saijo, M., Obuse, C., Tsurimoto, T., Nakayama, K.I., Nakayama, K., Fujita, M. et al. (2006) Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis. EMBO J., 25, 1126-1136.
27. Cortez, D., Guntuku, S., Qin, J. and Elledge, S.J. (2001) ATR and ATRIP: partners in checkpoint signaling. Science, 294, 1713-1716.
28. Zou, L. and Elledge, S.J. (2003) Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science, 300, 1542-1548.
29. Xu, N., Libertini, S., Black, E.J., Lao, Y., Hegarat, N., Walker, M. and Gillespie, D.A. (2012) Cdk-mediated phosphorylation of Chk1 is required for efficient activation and full checkpoint proficiency in response to DNA damage. Oncogene, 31, 1086-1094.
30. Palacios Eito, A., Cabezas, S.G., Ugalde, P.F., Del Campo, E.R., Romero, A.O., Martin, M.D., Arjona, J.M. and Paredes, M.M. (2012) Characterization and adequacy of the use of radiotherapy and its trend in time. Radiother. Oncol., 106, 260-265.
31. Majka, J., Binz, S.K., Wold, M.S. and Burgers, P.M. (2006) Replication protein A directs loading of the DNA damage checkpoint clamp to 5'-DNA junctions. J. Biol. Chem., 281, 27855-27861.
32. Ellison, V. and Stillman, B. (2003) Biochemical characterization of DNA damage checkpoint complexes: clamp loader and clamp complexes with specificity for 50 recessed DNA. PLoS Biol., 1, E33.
33. Kumagai, A., Lee, J., Yoo, H.Y. and Dunphy, W.G. (2006) TopBP1 activates the ATR-ATRIP complex. Cell, 124, 943-955.
34. Mordes, D.A., Glick, G.G., Zhao, R. and Cortez, D. (2008) TopBP1 activates ATR through ATRIP and a PIKK regulatory domain. Genes Dev., 22, 1478-1489.
35. Lee, J. and Dunphy, W.G. (2010) Rad17 plays a central role in establishment of the interaction between TopBP1 and the Rad9-Hus1-Rad1 complex at stalled replication forks. Mol. Biol. Cell, 21, 926-935.
36. Delacroix, S., Wagner, J.M., Kobayashi, M., Yamamoto, K. and Karnitz, L.M. (2007) The Rad9-Hus1-Rad1 (9-1-1) clamp activates checkpoint signaling via TopBP1. Genes Dev., 21, 1472-1477.
37. Cescutti, R., Negrini, S., Kohzaki, M. and Halazonetis, T.D. (2010) TopBP1 functions with 53BP1 in the G1 DNA damage checkpoint. EMBO J., 29, 3723-3732.
38. White, J.S., Choi, S. and Bakkenist, C.J. (2008) Irreversible chromosome damage accumulates rapidly in the absence of ATM kinase activity. Cell Cycle, 7, 1277-1284.
39. White, J.S., Choi, S. and Bakkenist, C.J. (2010) Transient ATM kinase inhibition disrupts DNA damage-induced sister chromatid exchange. Sci. Signal., 3, ra44.
40. Choi, S., Srivas, R., Fu, K.Y., Hood, B.L., Dost, B., Gibson, G.A., Watkins, S.C., Van Houten, B., Bandeira, N., Conrads, T.P. et al. (2012) Quantitative proteomics reveal ATM kinase-dependent exchange in DNA damage response complexes. J. Proteome Res., 11, 4983-4991.
41. Choi, S., Gamper, A.M., White, J.S. and Bakkenist, C.J. (2010) Inhibition of ATM kinase activity does not phenocopy ATM protein disruption: implications for the clinical utility of ATM kinase inhibitors. Cell Cycle, 9, 4052-4057.